PDCD1 and neoplasm: Some immune checkpoints (such as PD-1 and CTLA4) distinguish normal cells from cancer cells by recognizing their ligands on the cell surface, but some tumor cells evade the immune system by producing the ligands of immune checkpoints such as PD-L1 (Zhou et al., 2017).